• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • UK / Ireland

Bridges Ventures creates pharmacy platform

  • Alice Murray
  • Alice Murray
  • 02 June 2015
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Bridges Ventures has established The Hub Pharmacy, a community pharmacy platform aimed at increasing access to pharmacy and healthcare services.

Investing from its Bridges Sustainable Growth Fund III, which closed on £125m in 2013, The Hub has been created through the acquisition of Medicx Pharmacy Group and nine of its pharmacies in the north of England.

This group will form a platform from which Bridges will undertake a buy-and-build growth strategy in the region. The GP already has a number of deals in the pipeline. According to Bridges, the pharmacy sector is currently showing signs of consolidation. 

The GP has backed the company's management team, who have all invested in the new business.

The investment will see the nine pharmacies re-fitted to provide additional services including help with quitting smoking, weight loss and minor ailments. Furthermore, they will look to improve patient dosage adherence in order to tackle drug wastage.

This investment aims to improve NHS capacity by driving preventative care, reducing curative treatments by delivering services through pharmacies instead of doctors' surgeries and A&E units. Furthermore, the majority of the pharmacies are based in underserved locations, which will increase access to medicines and healthcare services for people who typically suffer from inferior health outcomes.

Company
Founded in 2007, Medicx Pharmacy focuses on technology-enabled, healthcare service-led pharmacies. The new business will share facilities with community organisations and work with local healthcare and community groups. A number of the pharmacies operate extended hours, providing late-night opening during the week and on weekends.

People
Steve Jeffers is CEO of Medicx Pharmacy; Andrew Butterworth is chief financial officer and Chris Ball is development director.

Bridges partner Oliver Wyncoll led the deal and will join the company's board, alongside investment manager James Hurrell.

Paul Forster-Jones has joined the board as non-executive chair, having previously worked with The Co-op Pharmacy, Alliance Boots and The Body Shop.

Advisers
Equity – Addleshaw Goddard, Mike Hinchliffe, Marc Field (Legal); PwC, Christine Adshead, Graeme Hurst (Financial due diligence); Parthenon, Paul Ahern, Matthew Webster (Commercial due diligence).
Company – Hollis Gore, Patrick Gore (Financial due diligence).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • UK / Ireland
  • Expansion
  • Healthcare
  • Bridges Ventures

More on UK / Ireland

Inflexion to exit Xtrac in SBO to MiddleGround Capital
Inflexion to exit Xtrac in SBO to MiddleGround Capital

Sale of UK-based transmission-systems manufacturer marks Buyout Fund IVт€™s seventh exit

  • UK / Ireland
  • 31 July 2023
Federated Hermes raises USD 486m for fifth co-investment fund
Federated Hermes raises USD 486m for fifth co-investment fund

Fund surpassed its USD 400m target; its 2018-vintage predecessor raised USD 600m against a USD 350m target

  • UK / Ireland
  • 12 July 2023
FPE Capital acquires, merges NoBlue and Elevate2
FPE Capital acquires, merges NoBlue and Elevate2

GPт€™s investment in NetSuite partners marks fifth investment out of third fund

  • UK / Ireland
  • 11 July 2023
Palatine reaps 6x money on SBO of Anthesis to Carlyle
Palatine reaps 6x money on SBO of Anthesis to Carlyle

GP will be reinvesting in UK-headquartered sustainability firm, acquiring a minority stake

  • UK / Ireland
  • 03 July 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013